UnitedHealth's recent performance has sent shockwaves through the industry, with a 16% drop in its stock price on Tuesday. The healthcare giant's announcement of a revenue contraction for 2026, coupled with a disappointing Medicare reimbursement proposal for 2027, has investors reevaluating their expectations.
The U.S. Medicare agency's decision to increase payment rates for Medicare Advantage plans by a mere 0.09% in 2027 fell short of Wall Street's anticipated 6% rise. This near-flat rate has caused a ripple effect, with shares across the sector taking a hit. CVS and Humana, for instance, saw premarket trading declines of 13% and 16.5%, respectively.
Analysts attribute these concerns to the potential decrease in government revenue from Medicare plans, which cater to individuals aged 65 and older or those with disabilities. UnitedHealth's struggles last year, including a cyberattack, unexpected medical fee increases, and the aftermath of a top executive's death, have deepened worries about the company's recovery prospects.
The company's CEO, Andrew Witty, was fired last year, and Steve Hemsley was brought back to lead the turnaround. James Harlow, a senior vice president at Novare Capital Management, an owner of UnitedHealth shares, expressed concerns about the proposal's impact on 2027 earnings growth and the ability of companies to meet Wall Street's expectations.
UnitedHealth's 2026 revenue forecast of over $439 billion represents a 2% year-over-year decline, falling short of analysts' average estimate of $454.6 billion. Julie Utterback, an analyst at Morningstar, noted that the guidance may have further dampened investor sentiment, potentially prolonging the wait for a quick turnaround.
Despite these challenges, UnitedHealth remains optimistic about its 2026 earnings growth, targeting an annual profit per share of over $17.75, slightly above analysts' average estimate. The company's 2025 adjusted earnings of $16.35 per share provide a foundation for this growth.
UnitedHealth's medical care ratio, which represents the percentage of premiums spent on medical care, is expected to be around 88.8% in 2026, slightly higher than analysts' expectations of 88.64%. The company's 2025 adjusted medical care ratio was 88.9%, compared to 85.5% in 2024, indicating a potential shift in cost management.
In the fourth quarter, UnitedHealth's adjusted earnings of $2.11 per share marginally exceeded market consensus. However, a one-time charge of $1.6 billion after taxes, related to the Change Healthcare cyberattack and restructuring costs, was excluded from these adjusted results.
This story is a reminder of the intricate balance between healthcare, government policies, and investor expectations. As UnitedHealth navigates these challenges, the industry awaits to see if the company can deliver on its promises and meet the expectations of its stakeholders.
